Hemifacial spasm

Hemifacial spasm
Name	Hemifacial spasm
Specialty	Neurology, Neurosurgery
Symptoms	unilateral involuntary facial muscle contractions
Onset	adulthood
Causes	vascular compression, tumors, demyelinating disease
Diagnosis	clinical examination, Magnetic resonance imaging, electromyography
Treatment	Botulinum toxin, microvascular decompression, medications
Frequency	rare

Hemifacial spasm is a neurological movement disorder characterized by intermittent, involuntary contractions of muscles on one side of the face. It typically begins with twitching of the orbicularis oculi and can progress to involve the mouth and platysma, producing socially disabling and functionally impairing symptoms often prompting consultation with specialists. Patients commonly present to clinics affiliated with Mayo Clinic, Johns Hopkins Hospital, or university centers such as Harvard Medical School and University of California, San Francisco where multidisciplinary teams including American Academy of Neurology members manage care.

Signs and symptoms

Patients experience unilateral, repetitive, tonic or clonic contractions that frequently begin in the periorbital region and spread to the zygomaticus, buccinator, and platysma muscles; early presentations are often mistaken for eyelid disorders evaluated by American Academy of Ophthalmology clinicians. Symptoms may be intermittent at onset and can progress to near-continuous contractions causing facial asymmetry, ocular irritation, and functional visual impairment prompting referrals from providers at centers like Cleveland Clinic or Massachusetts Eye and Ear. Associated complaints include social embarrassment, sleep disturbance, and secondary anxiety with patients sometimes seeking care from National Institutes of Health–affiliated specialists or psychological services at institutions such as Mayo Clinic and Johns Hopkins University.

Causes and pathophysiology

The predominant mechanism is vascular compression of the facial nerve root exit zone by an arterial loop, often involving the anterior inferior cerebellar artery or posterior inferior cerebellar artery identified in imaging studies performed at centers like Stanford University Medical Center or UCLA Health. Less common etiologies include mass lesions such as cerebellopontine angle tumors evaluated at institutions like Memorial Sloan Kettering Cancer Center and demyelinating conditions including plaques seen in Multiple sclerosis patients managed at specialized clinics like Cleveland Clinic Mellen Center. Pathophysiology theories implicate focal demyelination with ephaptic transmission and hyperexcitability of nuclei in the facial nerve pathway described in neurophysiology literature from groups at Columbia University and University of Oxford.

Diagnosis

Diagnosis is primarily clinical, established through history and observation by neurologists from organizations such as American Academy of Neurology and corroborated by neurologic examination performed in tertiary centers like Mount Sinai Health System. Ancillary testing includes high-resolution Magnetic resonance imaging studies—magnetic resonance angiography sequences performed at facilities such as Massachusetts General Hospital or Karolinska Institute—to identify vascular compression or tumor, and surface electromyography or blink reflex testing available in neurophysiology laboratories at Johns Hopkins Hospital and University College London to document abnormal synchronous discharges. Differential diagnosis includes focal dystonias and facial tics often evaluated by movement disorder specialists at centers like University of Pennsylvania and Mayo Clinic.

Treatment

First-line symptomatic management in many centers utilizes injections of Botulinum toxin performed by neurologists trained at institutions such as Mount Sinai Hospital and Charité – Universitätsmedizin Berlin to reduce muscular contractions; repeat injections are commonly administered in clinics affiliated with Oxford University Hospitals and University of Toronto. Definitive surgical treatment for neurovascular compression is microvascular decompression, an operation performed by neurosurgeons at high-volume centers including Cleveland Clinic and Mayo Clinic with reported durable relief in many series. Alternative approaches include anticonvulsants and muscle relaxants prescribed by neurologists at facilities like Massachusetts General Hospital and stereotactic procedures explored at specialized centers such as Barrow Neurological Institute.

Prognosis and complications

Prognosis varies: many patients achieve substantial symptomatic relief with repeated Botulinum toxin injections administered at multidisciplinary clinics like Johns Hopkins University or durable remission after microvascular decompression performed at referral centers including Mayo Clinic and Cleveland Clinic. Complications of chronic, untreated spasms include secondary skin changes, corneal exposure managed by ophthalmology services at Massachusetts Eye and Ear, and psychosocial morbidity leading patients to seek support from organizations such as National Alliance on Mental Illness. Surgical risks after microvascular decompression include hearing loss, facial weakness, and cerebrospinal fluid leak as reported in outcome studies from Stanford University Medical Center and UCLA Health.

Epidemiology

The condition is rare; epidemiologic series from population centers like Olmsted County, Minnesota and registries maintained by public health entities such as Centers for Disease Control and Prevention collaborators estimate prevalence in the range of several per 100,000, with onset most commonly in middle-aged adults and a female predominance described in studies from University of Tokyo and Seoul National University Hospital. Patterns of referral and care often involve tertiary centers including Mayo Clinic, Johns Hopkins Hospital, and university hospitals across Europe and Asia such as Karolinska University Hospital and Peking Union Medical College Hospital.

Category:Neurological disorders